Insider Transactions Reported by 15 Insiders of TFF Pharmaceuticals, Inc.

Location
Austin, TX

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

TFF Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Carlson Capital, L.P. 10%+ Owner $4,198,493 15 Aug 2023
Malcolm P. Fairbairn Director $519,876 19 May 2021
Harlan F. Weisman President and CEO, Director $347,373 03 Jul 2024
Zamaneh Mikhak Chief Medical Officer $61,005 03 Jul 2024
Robert S. Mills Director $24,989 03 Jul 2024
Kirk Allen Coleman Chief Financial Officer $22,109 03 Jul 2024
Stephen Rocamboli Director $17,165 03 Jul 2024
Glenn R. Mattes President and CEO, Director $16,839 16 May 2022
Brandi Roberts Director $11,159 03 Jul 2024
Catherine C. Lee Director $2,013 03 Jul 2024
Thomas B. King Director $1,838 03 Jul 2024
Michael A. Patane Director $1,393 18 Apr 2024
Christopher Cano Chief Operating Officer 22 Sep 2021
Randy H. Thurman Director 29 Sep 2022
Aaron G.l. Fletcher Director 29 Dec 2022

Recent Insider Transactions by Companies or Individuals for TFF Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.